Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000318

Type of data
NGS (Target Capture)
Access criteria
Controlled-access (Type I)
Total data volume
256 GB
File formats
  • FASTQ
  • BED
Research
hum0225
Date published
2020-09-28
Date modified
2020-11-18

Unrestricted-access files linked to this dataset

FileLabelSizeCopy URL
hum0225_TargetGeneList_280genes.xlsx280 genes including 50 candidate genes for ATL12.8 KB

Analysis method

Targeted DNA sequencing

Materials and participants
HAM (ICD-10: A858/B973): 21 cases (46 samples)
infected cells (tumor cells): 23 samples (including post-ATL specimens for 2 cases)
uninfected cells (non-tumor cells): 23 samples (including post-ATL specimens for 2 cases)
  • Health status
    Affected
  • Subject count
    46 (Sample)
Disease
HAM (A858, B973)
Sample description
DNAs extracted from PBMC (infected and uninfected cells) of HAM patients
  • Tissue
    PBMC, Peripheral blood
  • Tumor / normal
    Mixed
Sample provider
N/A
Experimental method
Targeted DNA sequencing
Target
280 genes (human) including 50 candidate genes for ATL and whole genome of HTLV-1 provirus
Reagent kit
SureSelect XT HS
Fragmentation
Ultrasonic fragmentation (Covaris)
Platform
Illumina HiSeq 2500
Illumina HiSeq 3000
Read type
Paired-end
Read length
100 bp